BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22879386)

  • 21. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of CD4+ and CD8+ T-lymphocytes in bone marrow associated with reduced erythropoiesis in patients with chronic inflammation and anaemia.
    Neidhart M; Brühlmann P; Gay S; Michel BA
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1618-23. PubMed ID: 9824895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological functions of Mycobacterium tuberculosis-specific CD4+T cells were impaired by tuberculosis pleural fluid.
    Li Q; Li L; Liu Y; Fu X; Wang H; Lao S; Yang B; Wu C
    Immunol Lett; 2011 Aug; 138(2):113-21. PubMed ID: 21549757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
    Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
    Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer-derived Foxp3(+) IL-17(+) T cells suppress tumour-specific CD8+ T cells.
    Ma C; Dong X
    Scand J Immunol; 2011 Jul; 74(1):47-51. PubMed ID: 21352252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
    Liu L; Wu G; Yao JX; Ding Q; Huang SA
    Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
    Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
    Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
    Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
    Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
    OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
    J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
    Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
    J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
    Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
    J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid.
    Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS
    Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LAP+CD4+T cells regulate the anti-tumor role of CIK cells in colorectal cancer through IL-10 and TGF-β.
    Zhong W; Fang C; Liu H; Zhang L; Zhang X; Zhong J; He X; Zhang L
    Am J Transl Res; 2022; 14(6):3716-3728. PubMed ID: 35836905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner.
    Boswell S; Sharif S; Alisa A; Pereira SP; Williams R; Behboudi S
    Immunology; 2011 Jul; 133(3):278-87. PubMed ID: 21426338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.